The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004
Diabetes Mellitus in Midlife and the Risk of Dementia Three Decades Later
Neurol 63:1902-1907, Beeri,M.S.,et al, 2004
Body Mass Index in Mid-Life Is Associated With a First Stroke in Men, A Prospective Population Study Over 28 Years
Stroke 35:2764-2769, Jood,K.,et al, 2004
Caffeine as a Risk Factor for Chronic Daily Headache, A Population-Based Study
Neurol 63:2022-2027, Scher,A.I.,et al, 2004
Cerebral Toxoplasmosis in a Patient with Common Variable Immunodeficiency
Neurol 63:2192-2193, Holtkamp,M.,et al, 2004
Hyperhomocysteinemia, Low Folate and Vitamin B12 Concentrations, and Methylene Tetrahydrofolate Reductase Mutation in Cerebral Venous Thrombosis
Stroke 35:1790-1794, Cantu,C.,et al, 2004
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
NEJM 351:2611-2618, Smeeth,L.,et al, 2004
Migraine and Other Headaches
Neurol 63:2233-2239,2209, Rose,K.M.,et al, 2004
Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004
Systematic Screening Allows Reduction of Adverse Antiepileptic Drug Effects
Neurol 62:23-27, Gilliam,F.G.,et al, 2004
Acquired Immunodeficiency Syndrome and the Risk of Stroke
Stroke 35:51-56, Cole,J.W.,et al, 2004
Tapeworms and Seizures--Treatment and Prevention
NEJM 350:215-217, Maguire,J.H., 2004
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
NEJM 350:249-258,215,280, Garcia,H.H.,et al, 2004
Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
The New Antiepileptic Drugs, Clinical Applications
JAMA 291:615-620, LaRoche,S.M.&Helmers,S.L., 2004
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients with Ischemic Stroke
JAMA 291:576-584, The APASS Investigators, 2004
Migraine as a Risk Factor for Subclinical Brain Lesions
JAMA 291:427-434, Kruit,M.C.,et al, 2004
Epilepsy
JAMA 291:654, Parmet,S, 2004
Recipients of Blood or Blood Products "at vCJD risk"
BMJ 328:118-119, Bird,S.M., 2004
Vertebrobasilar Dolichoectasia Diagnosed by Magnetic Resonance Angiography and Risk of Stroke and Death:A Cohort Study
JNNP 75:22-26, Ubogu,E.E.&Zaidat,O.O., 2004
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Periodontal Disease as a Risk Factor for Ischemic Stroke
Stroke 35:496-501, Crau,A.J.,et al, 2004
Tamoxifen:A New Risk Factor for Cerebral Sinus Thrombosis
Neurol 62:334-335, Masjuanh,J.,et al, 2004
Population Based Study of Early Risk of Stroke after Transient Ischaemic Attack or Minor Stroke:Implications for Public Education and Organisation of Services
BMJ 328:326-328,297, Coull,A.J.,et al, 2004
Transient Ischemic Attacks Before Ischemic Stroke: Preconditioning the Human Brain?
Stroke 35:616-621, Wegener,S.,et al, 2004
Anticardiolipin Antibodies and Risk of Ischemic Stroke and Transient Ischemic Attack
Stroke 35:736-741, Janardhan,V.,et al, 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Trpitans in Migraine
Neurol 62:563-568, Hall,G.C.,et al, 2004
Early Risk of Recurrence by Subtype of Ischemic Stroke in Population-Based Incidence Studies
Neurol 62:569-573, Lovett,J.K.,et al, 2004
Initial Misdiagnosis and Outcome After Subarachnoid Hemorrhage
JAMA 291:866-869, Kowalski,R.G.,et al, 2004
Frequency and Natural History of Subdural Haemorrhages in Babies and Relation to Obstetric Factors
Lancet 363:846-851, Whitby,E.H.,et al, 2004
Cognitive Side Effects of Antiepileptic Drugs in Children
Neurol 62:872-877, Loring,D.W.&Meador,K.J., 2004
The AED (Antiepileptic Drug) Pregnancy Registry
Arch Neurol 61:673-678, Holmes,L.B.,et al, 2004
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arch Neurol 61:661-666, Arvanitakis,Z.,et al, 2004
Risk Factors for Postherpetic Neuralgia in Patients with Herpes Zoster
Neurol 62:1545-1551, Jung,B.F.,et al, 2004
Carotid Artery Dissection After Prolonged Head Tilting While Holding a Newborn Baby to Sleep
Neurol 62:1647-1648, Soo,O.Y.,et al, 2004
Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004
Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Closure of a Patent Foramen Ovale is Associated with a Decrease in Prevalence of Migraine
Neurol 62:1439-1440, Post,M.C.,et al, 2004
Risk Factors for Obstructive Sleep Apnea in Adults
JAMA 291:2013-2016, Young,T.,et al, 2004
Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004
Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004
Late-Onset Seizures as a Predictor of Subsequent Stroke
Lancet 363:1184-1186,1175, Cleary,P.,et al, 2004
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Antiplatelet Drug Discontinuation is a Risk Factor for Ischemic Stroke
Neurol 62:1187-1189, Sibon,I. &Orgogozo,J-M., 2004
Magnetoencephalography (MEG) and Magnetic Source Imaging (MSI)
The Neurologist 10:138-153, Wheless,J.W.,et al, 2004